Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy – BSA bureau (press release)
BSA bureau (press release) |
Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy
BSA bureau (press release) Singapore: Mundipharma has announced a strategic partnership with Kolon Life Science to market Invossa, cell-medicated gene therapy for osteoarthritis, expected to be approved by the Korean Ministry of Food and Drug Safety (MFDS), in the second quarter … |
